
| If you would like to search the entire site, then use the search box below | |
| SEARCH | |
| CONTACT |
enquiries@mspl.co.uk (+44) 0161 226 1000 |
To view an article in full, please use the slideshow above, or select from the latest news below.
Corridor Manchester has today announced the appointment of a consortium of Bruntwood and Manchester Science Parks (msp) as the preferred developer and operator for the £21 million scheme to create a new 10,000 sq m centre for the bio-medical sector in the former Manchester Royal Eye Hospital on Oxford Road.
Phagenesis Ltd, a leader in technology for the treatment of swallowing dysfunction, has raised £2 million of investment to support the development of a new class of treatments for stroke patients who suffer from dysphagia, a common condition that prevents or impairs the safe swallowing of food and drink.
AdInsight, the
Read more: Clarity for marketing campaigns with new AdInsight software
Manchester Science Parks (msp) has welcomed new tenant, Name Your Number Ltd (NYN), to its Corridor site, one of msp’s four current locations.
Phagenesis Limited, a leader in technology for the treatment of stroke patients and newest tenant of msp's MedTECH Centre, has appointed Henry Hyde-Thomson as Chairman and Daniel Green as Chief Executive Officer.
Read more: MedTECH Centre tenant Phagenesis appoints Chairman and CEO
Page 1 of 19
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>